Mounjaro™ (tirzepatide) injection

2.5 mg/5 mg/7.5 mg/10 mg/12.5 mg/15 mg

This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.

Tirzepatide: Use in Patients With T1DM

Tirzepatide has not been studied in people with type 1 diabetes.


Detailed Information

There is no information on the use of tirzepatide in people with T1DM because patients with T1DM were excluded from tirzepatide clinical trials. At this time, we do not have plans to conduct tirzepatide clinical trials in people with T1DM.


T1DM = type 1 diabetes mellitus

Date of Last Review: March 02, 2021

Contact Lilly

Call Us

If you need information about a Lilly product or want to report an Adverse Event or Product Complaint, you may call us.

Available Mon – Friday, 9am-7pm (EST), excluding holidays

Or you can

Chat with us

Chat with us

Submit a Request

Visit Us @LillyMedical